HOME >> BIOLOGY >> NEWS
Emerging 'R&D' patterns in genes may reduce evolution's risks

The genetic blueprint at the heart of life may be divided into "research and development" and "production" sections, according to an author of a new study in this week's "Science" that compares genetic material in yeast, roundworms, insects and humans.

The distinction may help shunt the random genetic changes that cause evolution onto areas of the DNA where such changes have a better chance of benefitting the organism (the "R&D" section) and away from areas where they would more likely harm it (the "production" section).

"The great paradox of evolution is that you have many established functions to maintain in an organism, and how can you be conservative about those functions while experimenting to discover new and possibly advantageous gene functions?" says Edward Hedgecock, biology professor at The Johns Hopkins University.

If it is confirmed, the theory could aid researchers in their efforts to analyze genetic information from humans and other species.

With support from the National Institutes of Health, Hedgecock and other researchers conducted an extensive computerized comparison of the sequence of genetic information, known as genomes, found in yeast, the roundworm C. elegans and other nematodes, the fruit fly Drosophila, and humans.

New species arise throughout evolution. Comparing their genomes can therefore provide "snapshots" of the development of DNA at various points in evolutionary history. Since portions of DNA are used as instructions for building proteins, researchers can compare the details of these "snapshots" to get a feel for when life first developed various proteins.

If, for example, a gene for a protein is common to yeast and to animals, Hedgecock explains, then the protein's birth date was before the emergence of multicellular organisms.

Hedgecock and his coauthors focused most of their attention on proteins involved in the creation of
'"/>

Contact: Michael Purdy
mcp@jhu.edu
410-516-7160
Johns Hopkins University
9-Feb-2000


Page: 1 2 3

Related biology news :

1. International Conference on Emerging Infectious Diseases
2. Emerging frontiers genomics grant for blue-green bacteria
3. Emerging threats to tropical forests
4. Biological Challenges to Humanity: Emerging and Re-emerging Pathogens
5. 2002 International Conference on Emerging Infectious Diseases
6. Emerging trends: Scientific evidence in the courtroom
7. Emerging infectious diseases of wild animals are a threat to biodiversity and human health, according to new report
8. DNA Used To Create Self Assembling Conducting Wire: Breakthrough Will Lead To Next Leap In Emerging Nanoelectronics
9. Molecular Mechanochemistry: An Emerging Discipline At The Nexus Of Biology And Physics
10. Emerging Field Of Industrial Ecology
11. Outcome for acute lymphoblastic leukemia linked to gene expression patterns

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Emerging patterns genes may reduce evolution risks

(Date:3/24/2015)... 2015 Research and Markets ( http://www.researchandmarkets.com/research/hdgz7h/global_iris ... Iris Recognition Market 2015-2019" report to their offering. ... market to grow at a CAGR of 23.5 percent ... the present scenario and the growth prospects of the ... calculate the market size, the report considers the revenue ...
(Date:3/24/2015)... WASHINGTON , March 24, 2015   NexID ... applications with critical security-authentication needs, today announced the beginning ... fake-finger-detection (FFD) solution. The company, based in ... announcement at the three-day Connect:ID Expo, which began here ... NexID said version 2.0 of its SDK boosts ...
(Date:3/23/2015)... , March 23, 2015 SoundView Technology Group ... NXT-ID,s (NASDAQ: NXTD ) Wocket smart wallet. SoundView was one ... feedback on their experience with the Wocket in multiple scenarios ... CVS, Whole Foods and other retailers, making both debit and ... Tuttle also says, "If the company meets their plans ...
Breaking Biology News(10 mins):Global Iris Recognition Market 2015-2019 with 3M Cogent, Bioenable Technologies, Cross Match Technology, Iris ID Systems & Safran Dominating 2NexID Begins Shipments Of Version 2.0 Fake-Finger-Detection Solution 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 2Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 3Technology Research Note Update from SoundView; Real-World Usage and Feedback of Wocket Smart Wallet at CVS, Whole Foods and other Retailers 4
(Date:3/25/2015)...  S&P Capital IQ (MHFI) announced today that ... on Abattis Bioceuticals Corp . ... specialty biotechnology company with capabilities through its wholly ... ingredients, bio-similar compounds, patented equipment and consulting services ... . The company seeks to capitalize on ...
(Date:3/25/2015)... CAMBRIDGE, Mass. and REYKJAVIK, ... which provides comprehensive capabilities for using the genome to create ... their publication of the largest studies of whole-genome data yet ... in Nature Genetics – are built ... variation, authored by a team of deCODE scientists led by ...
(Date:3/25/2015)... 25, 2015 Data from Evidence ... of Action in Neuromuscular Diseases , South ... Incorporated (Nasdaq: CYTK) announced the publication of a ... activator tirasemtiv in the journal Neurotherapeutics. This ... of Effect” or hypothesis-generating clinical trial which evaluated ...
(Date:3/25/2015)... and the HAGUE, Netherlands , ... results of LES Stimulation therapy for chronic gastro-esophageal reflux ... Surgery [ Surgery . 2015; 157(3):556-567 ... its minimally-invasive therapy. The study included ... of 11 years and taking prescribed daily proton pump ...
Breaking Biology Technology:S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on Abattis Bioceuticals Corp. in S&P Capital IQ Factual Stock Reports 5Landmark deCODE Studies Demonstrate the Power of Truly Big Genomics for Improving Medicine Worldwide 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 2Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 3Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 4Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 5Cytokinetics Announces Publication of Results from Phase II Trial of Tirasemtiv in Patients with Myasthenia Gravis 6EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 2EndoStim LES Stimulation therapy demonstrates long term safety and efficacy results in treating reflux patients 3
Cached News: